- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT03293212
Characteristics and Medical Resource Utilization of Postoperative Patients
Characteristics and Medical Resource Utilization of Postoperative Patients: A Cross-sectional Survey of Outpatients
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
A considerable number of patients suffer prolonged chronic pain that does not retract or diminish after surgery, and are thus unable to achieve the desired results in receiving surgical treatment. Postoperative pain is gradually being perceived as a social issue as opposed to a personal health condition. Meanwhile, although efforts to address chronic pain with integrative medicine are continued in answer to the lack of success of pain management through surgery, there is still a lack of supporting evidence.
The objective of this survey study is to assess the characteristics, usage of conventional and Korean medical services, and prognosis by period before and after surgery in postoperative patients visiting a Korean medicine hospital, and analyze the associations between the preference for conventional and Korean medicine treatment. This study therefore investigates the usage of conventional and Korean medical services in postoperative patients, and is expected to provide information that will potentially aid patient decision making.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
-
Seoul, Corea, Repubblica di
- Jaseng Medical Foundation
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Patients with chief complaint(s) of at least one or more of the following: low back pain (or radiating leg pain), neck pain (or radiating arm pain), knee pain, or shoulder pain
- Patients with a history of musculoskeletal surgery related to the chief complaint(s)
- Patients capable of effective communication with the researcher(s) and understanding the survey items
- Patients who have given written informed consent
Exclusion Criteria:
- Patients without a history of musculoskeletal surgery associated with the low back, neck, shoulder, or knee region(s)
- Patients whose current pain is mainly attributed to traffic accident injury
- Patients incapable of answering the researcher interviews and surveys
- Patients with other reasons rendering study participation inappropriate as judged by the researcher(s)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Numeric rating scale (NRS) of pain
Lasso di tempo: Within 7 days after 1st visit
|
11-point pain scale
|
Within 7 days after 1st visit
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Five level version of EuroQol-5 Dimension (EQ-5D-5L)
Lasso di tempo: Within 7 days after 1st visit
|
Health-related quality of life questionnaire consisting of 5 descriptive items and EQ Visual Analogue Scales (EQ-VASs)
|
Within 7 days after 1st visit
|
|
Functional disability questionnaire (for low back pain patients as indicated by postoperative condition)
Lasso di tempo: Within 7 days after 1st visit
|
Oswestry Disability Index (ODI)
|
Within 7 days after 1st visit
|
|
Functional disability questionnaire (for neck pain patients as indicated by postoperative condition)
Lasso di tempo: Within 7 days after 1st visit
|
Neck Disability Index (NDI)
|
Within 7 days after 1st visit
|
|
Functional disability questionnaire (for knee pain patients as indicated by postoperative condition)
Lasso di tempo: Within 7 days after 1st visit
|
Western Ontario McMaster Universities Osteoarthritis Index (WOMAC)
|
Within 7 days after 1st visit
|
|
Functional disability questionnaire (for shoulder pain patients as indicated by postoperative condition)
Lasso di tempo: Within 7 days after 1st visit
|
Shoulder Pain and Disability Index (SPADI)
|
Within 7 days after 1st visit
|
|
Work Productivity and Activity Impairment Questionnaire: General Health (WPAI-GH)
Lasso di tempo: Within 7 days after 1st visit
|
Questionnaire assessing the effect of health problems on the ability to work and to perform regular activities
|
Within 7 days after 1st visit
|
|
Beck Depression Inventory-II (BDI-II)
Lasso di tempo: Within 7 days after 1st visit
|
The Korean version of the BDI-II has been validated and consists of 21 multiple choice items for diagnosis of depression.
|
Within 7 days after 1st visit
|
|
Medical service use
Lasso di tempo: Within 7 days after 1st visit
|
Type(s) of medical service use before and after surgery post-onset
|
Within 7 days after 1st visit
|
|
Medical costs
Lasso di tempo: Within 7 days after 1st visit
|
Medical costs from medical service use before and after surgery post-onset
|
Within 7 days after 1st visit
|
|
Satisfaction with and preference for conventional and Korean medicine
Lasso di tempo: Within 7 days after 1st visit
|
Satisfaction with and preference for conventional and Korean medicine as measured using a 9-point Likert scale
|
Within 7 days after 1st visit
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: In-Hyuk Ha, KMD, M.Sc., Jaseng Medical Foundation
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- JS-CT-2017-03
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .